Evidence map›Paper›PMID 32397571›Full record

ArticleViruses2020

Glucose-Regulated Protein 78 Interacts with Zika Virus Envelope Protein and Contributes to a Productive Infection.

Jamie Royle, Carolina Ramírez-Santana, Snezhana Akpunarlieva, Claire L Donald, Rommel J Gestuveo, Juan-Manuel Anaya, Andres Merits, Richard Burchmore, Alain Kohl, Margus Varjak

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Parasitology · 2023
    Article
  13. Article
  14. Article
  15. Article
  16. In silico identification of available drugs targeting cell surface BiP to disrupt SARS-CoV-2 binding and replication: Drug repurposing approach.European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences · 2021
    Article
  17. Article
  18. Review
  19. aBravo Is a NovelViruses · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 4 countries.

Jamie RoyleMRC-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UK.
Carolina Ramírez-SantanaCenter for Autoimmune Diseases Research-CREA, School of Medicine and Health Sciences, Universidad del Rosario, 110010 Bogotá, Colombia.
Snezhana AkpunarlievaInstitute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, UK.
Claire L DonaldMRC-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UK.ORCID 0000-0002-4370-0707
Rommel J GestuveoMRC-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UK.ORCID 0000-0002-4609-3551
Juan-Manuel AnayaCenter for Autoimmune Diseases Research-CREA, School of Medicine and Health Sciences, Universidad del Rosario, 110010 Bogotá, Colombia.
Andres MeritsInstitute of Technology, University of Tartu, 50411 Tartu, Estonia.
Richard BurchmoreInstitute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, UK.ORCID 0000-0003-1663-9004
Alain KohlMRC-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UK.
Margus VarjakMRC-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UK.ORCID 0000-0003-2608-5148
MRC University of Glasgow Centre for Virus Research · GBUniversidad del Rosario · COUniversity of Glasgow · GBUniversity of Tartu · EEUniversity of the Philippines Visayas · PH

Funding

Medical Research Council MC_UU_12014/8Medical Research Council MR/N017552/1Medical Research Council MR/S019650/1
6 · The paper itself

Abstract

Zika virus (ZIKV; Flaviviridae) is a mosquito-borne flavivirus shown to cause fetal abnormalities collectively known as congenital Zika syndrome and Guillain-Barré syndrome in recent outbreaks. Currently, there is no specific treatment or vaccine available, and more effort is needed to identify cellular factors in the viral life cycle. Here, we investigated interactors of ZIKV envelope (E) protein by combining protein pull-down with mass spectrometry. We found that E interacts with the endoplasmic reticulum (ER) resident chaperone, glucose regulated protein 78 (GRP78). Although other flaviviruses are known to co-opt ER resident proteins, including GRP78, to enhance viral infectivity, the role ER proteins play during the ZIKV life cycle is yet to be elucidated. We showed that GRP78 levels increased during ZIKV infection and localised to sites coincident with ZIKV E staining. Depletion of GRP78 using specific siRNAs significantly reduced reporter-virus luciferase readings, viral protein synthesis, and viral titres. Additionally, GRP78 depletion reduced the ability of ZIKV to disrupt host cell translation and altered the localisation of viral replication factories, though there was no effect on viral RNA synthesis. In summary, we showed GRP78 is a vital host-factor during ZIKV infection, which may be involved in the coordination of viral replication factories.

Indexed as

Virus ReplicationEndoplasmic ReticulumEndoplasmic Reticulum Chaperone BiPHeat-Shock ProteinsHost-Pathogen InteractionsHumansProtein BindingViral Envelope ProteinsZika VirusZika Virus InfectionEndoplasmic Reticulum Chaperone BiPHeat-Shock ProteinsHSPA5 protein, humanViral Envelope ProteinsGRP78proteomicsvirus–cell interactionsZika virus

Identifiers

PMID32397571
PMCPMC7290722
OpenAlexW3020869136

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.